Skip to main navigation Skip to search Skip to main content

Insulin inhalation with absorption enhancer at meal-times results in almost normal postprandial insulin profiles.

Lars-Olof Almér, Per Wollmer, Björn Jonson, Anneli Troedsson Almér

Research output: Contribution to journalArticlepeer-review

207 Downloads (Pure)
Original languageEnglish
Pages (from-to)218-221
JournalClinical Physiology and Functional Imaging
Volume22
Issue number3
DOIs
Publication statusPublished - 2002

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Internal Medicine (013242500), Department of Clinical Physiology (Lund) (013013000), Clinical Physiology (013242300), Clinical Physiology and Nuclear Medicine Unit (013242320), Internal Medicine Research Unit (013242520)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Subject classification (UKÄ)

  • Physiology and Anatomy

Free keywords

  • Hypoglycemic Agents: administration & dosage
  • Human
  • Inhalation
  • Adult
  • Aged
  • Diabetes Mellitus
  • Administration
  • Insulin-Dependent: drug therapy
  • Dioctyl Sulfosuccinic Acid: administration & dosage
  • Female
  • Hypoglycemic Agents: blood
  • Hypoglycemic Agents: pharmacokinetics
  • Insulin: administration & dosage
  • Insulin: blood
  • Insulin: pharmacokinetics
  • Male
  • Middle Age
  • Postprandial Period
  • Surface-Active Agents: administration & dosage

Cite this